Jupiter Neurosciences, Inc. (JUNS): Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati
Jupiter Neurosciences Inc (JUNS) rahbariyati neyrodegeneratsiyaga qarshi kurashish uchun ilg'or dori yetkazib berish usullarini ishlab chiqishga e'tibor qaratgan. PEG ko'rsatkichi biznesning baholanishini tahlil qilishga yordam beradi, bunda joriy parametr 0.00 ni tashkil etadi. Kompaniyaning daromadlari epilepsiya va Altsgeymer kasalligini davolash uchun resveratrolga asoslangan dori vositalarini (JUP-07) bozorga chiqarishga bog'liq. Dasturiy robotlar va molekulalarni avtomatlashtirilgan holda skrining qilish texnologik stekni to'ldiradi.
%20PEG%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_JUNS_-_Jupiter-Neurosciences-Inc_-_PEG-Multiple "JUNS - Jupiter Neurosciences, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati 04.12.2024 - 11.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Jupiter Neurosciences (JUNS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Jupiter Neurosciences Inc|JUNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Jupiter Neurosciences, Inc.|JUNS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Jupiter Neurosciences|JUNS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Jupiter Neurosciences|Shoshilinch likvidlik jupiterneurosciences.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
JUNS - Sof daromad|Prognoz qilingan kelajakdagi foyda Jupiter Neurosciences Inc|JUNS - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori jupiterneurosciences.com|JUNS - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Jupiter Neurosciences|JUNS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Jupiter Neurosciences|JUNS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi jupiterneurosciences.com|JUNS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Jupiter Neurosciences Inc
Kompaniyaning jamlanma tahliliyoti:jupiterneurosciences.com, JUNS
Jupiter Neurosciences Inc (JUNS) rivojlanishi barqaror daromadga erishishdan oldin uning tadqiqot va ishlanmalar (R&D) portfeli muvaffaqiyatiga hamda kapital xarajatlar nazoratiga kritik darajada bog'liq. Bunday sharoitda, PEG koeffitsiyenti joriy P/E ko'paytirgichini foyda o'sish sur'atlari bilan solishtiradi. Ushbu metrika aktivning kengayish dinamikasini hisobga olgan holda uning adolatli qiymatini belgilaydi. Birga solishtirganda pastroq qiymatlar biznesning o'z salohiyatiga nisbatan past baholanganligidan dalolat beradi. PEG koeffitsiyenti yordamida tahlil qilish tendentsiya qaytish nuqtalarini aniqlash imkonini beradi.
Jupiter Neurosciences Inc raqobatchilari
PEG multiplikatori Biogen Inc (BIIB)|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|RGC (Regencell Corp) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|XENE (Xenon) - Narx-foyda va o‘sish multiplikatori|VKTX: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SUPN (Supernus Pharma) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Catalyst Corp CPRX|Narxning foydaga va o‘sish sur’atiga nisbati Denali Therapeutics (DNLI)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Biohaven - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|PRAX (Praxis Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AVXL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda ceribell.com (CBLL)|Narx-foyda va o‘sish multiplikatori PRTA|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER (omeros.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|SCLX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tevogen Bio Inc.|ACOG (Alpha Cognition Inc) - PEG multiplikatori|cogrx.com (CGTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori IKT|SAVA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|COYA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VistaGen Therapeutics Inc - PEG multiplikatori|Ovid Therapeutics Inc. (OVID) - Narx-foyda va o‘sish multiplikatori|ABOS: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda CervoMed, Inc. (CRVO)|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|Clene Nanomedicine (CLNN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori PEPG (PepGen Inc.)|RLMD (relmada.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANVS (Annovis Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Therapeutics Inc (GRCE)|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|KLTO (Klotho Neurosciences Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|NRSN: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori revivapharma.com|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|NRXS (NeurAxis Inc.) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori HSDT (Helius Medical)|PEG multiplikatori passagebio.com (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|NERV: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Addex Therapeutics Ltd. ADXN|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CYCN|PTIX (Protagenic Therapeutics Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CARA|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori MRNS|PEG multiplikatori NKGen Biotech Corp|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SNPX (Synaptogenix)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Trevena Inc. (TRVN)|VIGL: Narx-foyda va o‘sish multiplikatori|Anew Medical Inc. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CERE: PEG multiplikatori
